Last reviewed · How we verify
BI-1206 single agent expansion phase — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
BI-1206 single agent expansion phase (BI-1206 single agent expansion phase) — Cancer Research UK.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BI-1206 single agent expansion phase TARGET | BI-1206 single agent expansion phase | Cancer Research UK | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BI-1206 single agent expansion phase CI watch — RSS
- BI-1206 single agent expansion phase CI watch — Atom
- BI-1206 single agent expansion phase CI watch — JSON
- BI-1206 single agent expansion phase alone — RSS
Cite this brief
Drug Landscape (2026). BI-1206 single agent expansion phase — Competitive Intelligence Brief. https://druglandscape.com/ci/bi-1206-single-agent-expansion-phase. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab